drugset

drugset / Trial / NCT00104130

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

NCT00104130 ↗

Phase 2 Terminated 53 enrolled Bristol-Myers Squibb

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.

Timeline

Start: 2004-12
Primary completion: —
Completion: 2005-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Epothilone D	Small molecule	—	Intravenous

Indications